EyePoint Inc
EYPT
66 hedge funds and large institutions have $85.6M invested in EyePoint Inc in 2023 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 19 increasing their positions, 18 reducing their positions, and 16 closing their positions.
492% more call options, than puts
Call options by funds: $213K | Put options by funds: $36K
6% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 18
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
1.12% less ownership
Funds ownership: 85.99% → 84.87% (-1.1%)
10% less funds holding
Funds holding: 73 → 66 (-7)
17% less capital invested
Capital invested by funds: $103M → $85.6M (-$17M)
44% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 16
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$1.28M |
| 2 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$803K |
| 3 |
Squarepoint
New York
|
+$235K |
| 4 |
Morgan Stanley
New York
|
+$231K |
| 5 |
Renaissance Technologies
New York
|
+$169K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
-$1.71M |
| 2 |
BlackRock
New York
|
-$555K |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
-$324K |
| 4 |
Tudor Investment Corp
Stamford,
Connecticut
|
-$245K |
| 5 |
Verition Fund Management
Greenwich,
Connecticut
|
-$243K |
EYPT Hedge Fund Activity: Q1 2023 in Review
66 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in EyePoint Inc (EYPT) for Q1 2023, worth a combined $85.6M — down 17% from $103M a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of EYPT and 9 opened new positions — a net loss of 7 holders — while 18 trimmed existing stakes and 19 added.
The largest buyer was Citadel Advisors, adding an estimated $1.28M. The largest seller was OrbiMed, exiting entirely with an estimated $1.71M sold.
- 66 institutional investors held EyePoint Inc (EYPT) as of Q1 2023, down from 73 in Q4 2022.
- Funds reported $85.6M of EyePoint Inc stock for Q1 2023, down 17% quarter-over-quarter.
- 9 funds opened new EyePoint Inc positions in Q1 2023 and 16 closed out, a net change of -7 holders.
- The largest EyePoint Inc buyer in Q1 2023 was Citadel Advisors, an estimated $1.28M added.
- The largest EyePoint Inc seller in Q1 2023 was OrbiMed, an estimated $1.71M sold.
Based on aggregated 13F filings for Q1 2023.